1)warfarin[英]['w?:f?rin][美]['w?rf?r?n]华法林
1.Anticoagulation of Warfarin Therapy in Patients After Mechanical Valve Implantation;心脏机械瓣膜置换术后华法林抗凝观察
2.The Randomized Study of Efficiency and Safety of Antithrombotic Therapy with Warfarin in Nonvalvular Atrial Fibrillation.;华法林预防非瓣膜性心房颤动并发脑卒中的临床研究
3.Study on the Association between the Maintenance Dose of Warfarin Anticoagulation Therapy and the Genetic Mutation of Cytochrome P450 (CYP2C9);华法林抗凝治疗维持剂量与CYP2C9基因突变的关系
英文短句/例句
1.Clinical Study of Warfarin in Treating Atrial Fibrillation in the Old Patients;老年房颤患者应用华法林的临床研究
2.Introduction of Clinical Therapy and Bleeding Complication of Warfarin华法林临床应用及出血不良反应介绍
3.Corpus luteum rupture induced by warfarin overdose:one case report华法林过量致卵巢黄体破裂1例分析
4.Diet Nursing of Warfarin Anticoagulation Treatment in Atrial Fibrillation Patients房颤患者华法林抗凝治疗的饮食调护
5.Anticoagulant therapy of Warfarin in patients with no-valvular heart disease and atrial fibrillation非瓣膜病房颤的华法林抗凝治疗研究
6.The Synthesis of Coumarin Anticoagulants Warfarin and It's Analogs;香豆素类抗凝血药华法林及其类似物的合成
7.The Influence of PXR and OATP1B1 Gene Polymorphism on Therapeutic Dose of Warfarin核受体PXR和OATP1B1基因多态性对华法林剂量的影响
8.In Vitro Metabolism and Drug Interactions of Warfarin华法林的体外代谢及药物相互作用研究
9.Clinical observation of Warfarin in the treatment of 27 cases of lower limb deep venous thrombosis华法林治疗下肢深静脉血栓27例疗效观察
10.Clinical Analysis on Hematuria Caused by Oral Warfarin among Elderly Patients老年患者服用华法林导致血尿的临床分析
11.Clinical Study of Warfarin Anticoagulation Therapy in Patients after Mechanical Heart Valve Replacement心脏机械瓣膜置换术后华法林抗凝治疗的研究
12.Therapeutic Monitoring Anticoagulation of Warfarin in Patients with Prosthetic Heart Valve Replacement;人工机械心脏瓣膜置换术后华法林抗凝治疗的监测
13.Study on CYP2C9 Polymorphism and Warfarin Dosage Requirement in Population of Han Nationality in China;中国汉族人CYP2C9遗传多态性与华法林剂量调整的研究
14.The Efficiency and Safety of Anticoagulation Therapy by Combination of Herbs with Effects of Activating Blood Circulation and Dispersing Stasis and Warfarin Sodium in Chronic Atrial Fibrillation in Chinese;活血化瘀药联合华法林对慢性房颤抗凝疗效及安全性观察
15.The Effect of CYP2C9 SNP on the Warfarin s Stable Doses of 30 Chinese Mongolian Heart Disease Patients;CYP2C9基因的多态性对30名汉族心脏病患者华法林稳定维持量的影响
16.The Effect of Danshen on Steady State Warfarin Pharmacodynamics and Pharmacokinetics in Rats;丹参注射液对大鼠体内稳态华法林药动学和药效学参数的影响
17.Gene Polymorphism of CYP450 2C9 and VKORC1 and Their Relationship with Warfarin Maintaining Dose;CYP4502C9和VKORC1的基因多态性及其他因素与华法林剂量的相关性研究
18.The Effects of Soybean Isoflavone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Volunteers;大豆异黄酮对健康人体内华法林药动学和药效学的影响
相关短句/例句
Warfarin sodium华法林钠
1.Study use of warfarin sodium after mechanical heart valve replacement;心脏机械瓣膜置换术后华法林钠的应用调查与分析
2.Polarography Determination of Warfarin Sodium;极谱法测定华法林钠的含量
3.Objective:Based on the spectrum characteristic of warfarin sodium,a new analytical method was pro- posed to determine warfarin sodium in the medium of aqueous-alcoholic.目的:基于华法林钠的荧光光谱特性,以水-乙醇混合溶剂为介质,研究建立了一种测定华法林钠的荧光光谱分析方法。
3)Warfarin potassium tablets华法林钾片
4)warevan tablet华法林钠片
5)Warfarin/therapeutic use华法林/治疗应用
6)Oral dose of warfarin华法林血药浓度
延伸阅读
华法林分子式：CAS号：性质：又名华法令，杀鼠灵。为从乙醇中结晶。其钾盐为无色或无臭结晶性粉末，味微苦，遇光变色。钠盐为无臭白色无定型结晶性粉末，味微苦，遇光变色。熔点159～161℃。不溶于水、环己烷苯和石油醚，稍溶于甲醇、乙醇和异丙醇，易溶于丙酮和二氧六环。其烯醇式可与金属离子生成盐，盐溶于水，钠盐较稳定。(S)型从丙酮中结晶。由苄基丙酮与4-羟基香豆素缩合制得。为抑制肝细胞中凝血酶原和凝血因子II，VII，IX和X的合成，防止血栓形成药。适用于冠状动脉血栓、肺栓塞、血栓闭塞性脉管炎等症。制剂有注射剂，片剂(华法林钠片)。副作用为服药过量可轻微出血，偶有脱发、发热、呕吐等。是20世纪40年代出现的第一代抗凝血杀鼠剂。S型比R型对鼠毒力约大7倍。口服急性LD50(mg/kg)：58(黑家鼠)；374(小家鼠)；186(褐家鼠)；200～300(狗)。
